193 related articles for article (PubMed ID: 32682912)
1. C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.
Jackson WD; Gulino A; Fossati-Jimack L; Castro Seoane R; Tian K; Best K; Köhl J; Belmonte B; Strid J; Botto M
J Invest Dermatol; 2021 Feb; 141(2):404-414.e6. PubMed ID: 32682912
[TBL] [Abstract][Full Text] [Related]
2. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
3. C3aR and C5aR1 act as key regulators of human and mouse β-cell function.
Atanes P; Ruz-Maldonado I; Pingitore A; Hawkes R; Liu B; Zhao M; Huang GC; Persaud SJ; Amisten S
Cell Mol Life Sci; 2018 Feb; 75(4):715-726. PubMed ID: 28921001
[TBL] [Abstract][Full Text] [Related]
4. Complement deficiency promotes cutaneous wound healing in mice.
Rafail S; Kourtzelis I; Foukas PG; Markiewski MM; DeAngelis RA; Guariento M; Ricklin D; Grice EA; Lambris JD
J Immunol; 2015 Feb; 194(3):1285-91. PubMed ID: 25548229
[TBL] [Abstract][Full Text] [Related]
5. Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
Oikonomopoulou K; DeAngelis RA; Chen H; Diamandis EP; Hollenberg MD; Ricklin D; Lambris JD
J Immunol; 2013 Oct; 191(7):3858-66. PubMed ID: 24014879
[TBL] [Abstract][Full Text] [Related]
6. Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.
Honkanen HK; Izzi V; Petäistö T; Holopainen T; Harjunen V; Pihlajaniemi T; Alitalo K; Heljasvaara R
Neoplasia; 2016 Jul; 18(7):436-46. PubMed ID: 27435926
[TBL] [Abstract][Full Text] [Related]
7. Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells.
Qu M; Muller HK; Woods GM
Carcinogenesis; 1997 Jun; 18(6):1277-9. PubMed ID: 9214614
[TBL] [Abstract][Full Text] [Related]
8. Complement inhibition alleviates paraquat-induced acute lung injury.
Sun S; Wang H; Zhao G; An Y; Guo Y; Du L; Song H; Qiao F; Yu H; Wu X; Atkinson C; Jiang S; Tomlinson S; Zhou Y
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):834-42. PubMed ID: 21421909
[TBL] [Abstract][Full Text] [Related]
9. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract][Full Text] [Related]
10. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4
Hansen CB; Willer A; Bayarri-Olmos R; Kemper C; Garred P
Immunobiology; 2019 Mar; 224(2):307-315. PubMed ID: 30612786
[TBL] [Abstract][Full Text] [Related]
11. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
12. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
Williams AL; Gullipalli D; Ueda Y; Sato S; Zhou L; Miwa T; Tung KS; Song WC
Kidney Int; 2017 Jun; 91(6):1386-1397. PubMed ID: 28139294
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
14. Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
Sato Y; Fujimura T; Hidaka T; Lyu C; Tanita K; Matsushita S; Yamamoto M; Aiba S
Front Immunol; 2020; 11():534323. PubMed ID: 33178182
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
Ueda Y; Miwa T; Ito D; Kim H; Sato S; Gullipalli D; Zhou L; Golla M; Song D; Dunaief JL; Palmer MB; Song WC
Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
[TBL] [Abstract][Full Text] [Related]
16. Complement: a novel factor in basal and ischemia-induced neurogenesis.
Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
[TBL] [Abstract][Full Text] [Related]
17. Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.
Sun S; Guo Y; Zhao G; Zhou X; Li J; Hu J; Yu H; Chen Y; Song H; Qiao F; Xu G; Yang F; Wu Y; Tomlinson S; Duan Z; Zhou Y
PLoS One; 2011; 6(11):e26838. PubMed ID: 22069473
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
19. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]